Plante Moran Financial Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Plante Moran Financial Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$104	Buy	+6	New	+$82	﹤0.01%	1541

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Westshore Wealth Newport Beach, California $322M AUM 24.46% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Plante Moran Financial Advisors's AMRX Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 6 shares worth $104. The stake represents ﹤0.01% of the portfolio and ranks #1541 among its holdings.

136 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Plante Moran Financial Advisors held 6 shares of Amneal Pharmaceuticals worth $104 as of Q2 2026.
Amneal Pharmaceuticals was a new Plante Moran Financial Advisors position in Q2 2026.
Amneal Pharmaceuticals made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1541 holding.
136 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.